Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Compérat

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
European Urology|November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial CarcinomaRichard Cathomas, Anja Lorch, Harman M Bruins, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 26, 2023
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateMorgan Rouprêt, Thomas Seisen, Alison J Birtle, et al.
European Urology Oncology|January 8, 2025
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology GuidelinesBhavan Prasad Rai, Kalpesh Parmar, Benjamin Pradere, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
European Urology Focus|August 1, 2018
Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?Marko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
European Urology Focus|November 22, 2017
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder CancerJose Luis Dominguez-Escrig, Benoit Peyronnet, Thomas Seisen, et al.
European Urology Oncology|July 14, 2026
FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result ReportingEva M Compérat, Arndt Hartmann, Yves Allory, et al.
European Urology|November 7, 2021
The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial CarcinomaRichard Cathomas, Anja Lorch, Harman M Bruins, et al.
Histopathology|June 27, 2022
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancerJames G Kench, Mahul B Amin, Daniel M Berney, et al.
European Urology Oncology|January 1, 2026
Perioperative and Oncological Outcomes of Distal Ureterectomy for Upper Tract Urothelial Carcinoma (UTUC): A Multicentre Study from the European Association of Urology Non-muscle-invasive Bladder Cancer/UTUC Guidelines Panels with a Focus on Survival Free from Ipsilateral UTUC RecurrenceFrancesco Soria, Frederik Liedberg, Elin Stahl, et al.
European Urology|March 26, 2023
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 UpdateMorgan Rouprêt, Thomas Seisen, Alison J Birtle, et al.
European Urology Oncology|January 8, 2025
Benefit and Harms of Radical Nephroureterectomy as Part of a Multimodal Treatment Strategy for Upper Tract Urothelial Carcinoma Patients Presenting with Clinical Evidence of Regional Lymph Node Metastasis: A Systematic Review and Meta-analysis by the European Association of Urology GuidelinesBhavan Prasad Rai, Kalpesh Parmar, Benjamin Pradere, et al.
Pageof 5